FIRM FIXED PRICE
TEVA PHARMACEUTICALS USA, INC. - 8511784113!ADENOVIRUS TYPE 4 A
PIID: SPE2DP26F0984
Signed Date: Dec 1, 2025Effective Date: Dec 1, 2025End Date: Closed on Dec 9, 2025
Key Details
Description
8511784113!ADENOVIRUS TYPE 4 A
Contractor Information
Contractor: TEVA PHARMACEUTICALS USA, INC.
UEI: NEN9A34LRHJ5
CAGE Code: 3V8D7
Location: NORTH WALES, PA
Similar Awards
LUTATHERA AND PLUVICTO
NOVARTIS PHARMACEUTICALS CORPORATION
$3.2M
8511784063!ADENOVIRUS TYPE 4 A
TEVA PHARMACEUTICALS USA, INC.
$2.0M
8511784064!ADENOVIRUS TYPE 4 A
TEVA PHARMACEUTICALS USA, INC.
$1.3M
4569692252!RSDL
CANADIAN COMMERCIAL CORPORATION
$747,796
8511784112!ADENOVIRUS TYPE 4 A
TEVA PHARMACEUTICALS USA, INC.
$660,627.72
Stay Updated
Get notified about new opportunities matching your interests.
Related
Agencies